These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 21168208)

  • 1. Simultaneous acute myeloid leukaemia and de novo acute hepatitis B: a novel management strategy.
    Parrish C; Moreton P; Ashcroft J
    Leuk Res; 2011 Jun; 35(6):e67-8. PubMed ID: 21168208
    [No Abstract]   [Full Text] [Related]  

  • 2. [Advances in the treatment of acute hepatitis B].
    Mochida S; Fujiwara K
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():248-52. PubMed ID: 15453324
    [No Abstract]   [Full Text] [Related]  

  • 3. The management of blastic crisis of chronic myeloid leukaemia with thioguanine, rubidomycin, ARA C and prednisone (TRAP regimen).
    Resegotti L; Falda M; Rossi M; Infelise VE
    Panminerva Med; 1973 Sep; 15(9):275-7. PubMed ID: 4533778
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis B virus-related membranous nephropathy treated with entecavir.
    Ikee R; Ishioka K; Oka M; Maesato K; Moriya H; Hidaka S; Ohtake T; Kobayashi S
    Nephrology (Carlton); 2010 Mar; 15(2):266. PubMed ID: 20470290
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful Treatment of Hepatitis B Virus-associated Membranous Nephropathy with Entecavir and Immunosuppressive Agents.
    Ochi A; Ishimura E; Ichii M; Ohno Y; Nakatani S; Kobayashi I; Shima H; Tsuda A; Shidara K; Mori K; Tamori A; Inaba M
    Nephrology (Carlton); 2014 Sep; 19(9):595-6. PubMed ID: 25156438
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination of liposomal daunorubicin (DaunoXome), fludarabine, and cytarabine (FLAD) in patients with poor-risk acute leukemia.
    Clavio M; Venturino C; Pierri I; Garrone A; Miglino M; Canepa L; Balleari E; Balocco M; Michelis GL; Ballerini F; Gobbi M
    Ann Hematol; 2004 Nov; 83(11):696-703. PubMed ID: 15322763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adriamycin-cytosine arabinoside therapy for adult acute myelocytic leukemia.
    Preisler HD; Bjornsson S; Henderson ES
    Cancer Treat Rep; 1977; 61(1):89-92. PubMed ID: 324625
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognosis of acute leukaemia in adults.
    Penington DG; Keating MJ
    Med J Aust; 1974 Jun; 1(26):1031-5. PubMed ID: 4527947
    [No Abstract]   [Full Text] [Related]  

  • 9. Entecavir to treat severe acute hepatitis B.
    De Socio GV; Mercuri A; Di Candilo F; Baldelli F
    Scand J Infect Dis; 2009; 41(9):703-4. PubMed ID: 19544224
    [No Abstract]   [Full Text] [Related]  

  • 10. Effectiveness of entecavir in the management of acute hepatitis B developing in a patient with Hodgkin's lymphoma: a case report.
    Begini P; Cox MC; Angeletti S; Gigante E; Baccini F; Di Fonzo M; Delle Fave G; Marignani M
    Scand J Infect Dis; 2011 Sep; 43(9):750-2. PubMed ID: 21696249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current treatment and prognosis of chronic myeloid leukemia].
    Jacquillat C; Weil M; Gemon-Auclerc MF
    Sem Hop Ther; 1976 Mar; 52(3):175-9. PubMed ID: 1070161
    [No Abstract]   [Full Text] [Related]  

  • 12. Prospective cytomegalovirus monitoring during first-line chemotherapy in patients with acute myeloid leukemia.
    Capria S; Gentile G; Capobianchi A; Cardarelli L; Gianfelici V; Trisolini SM; Foà R; Martino P; Meloni G
    J Med Virol; 2010 Jul; 82(7):1201-7. PubMed ID: 20513085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of acute myelogenous leukaemia in adults. A retrospective study of 70 patients (1968-1973).
    Willemze R; Hartgrink-Groeneveld CA; Speck B; Eernisse JG
    Neth J Med; 1975; 18(1):17-28. PubMed ID: 1055303
    [No Abstract]   [Full Text] [Related]  

  • 14. [Recent advances in the treatment of fulminant hepatitis B].
    Yoshiba M
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():280-3. PubMed ID: 15453330
    [No Abstract]   [Full Text] [Related]  

  • 15. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
    Lu C; Hassan HT
    Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Very few hepatitis trials recruiting.
    AIDS Patient Care STDS; 1998 Apr; 12(4):319-20. PubMed ID: 11361965
    [No Abstract]   [Full Text] [Related]  

  • 17. [New advances in the treatment of chronic hepatitis B: position of entecavir].
    Olaso V
    Rev Esp Quimioter; 2007 Sep; 20(3):259-60. PubMed ID: 18080023
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term outcome of intensive chemotherapy for adults with de novo acute myeloid leukaemia (AML): the nationwide AML-92 study by the Finnish Leukaemia Group.
    Koistinen P; Räty R; Itälä M; Jantunen E; Koivunen E; Nousiainen T; Pelliniemi TT; Remes K; Ruutu T; Savolainen ER; Siitonen T; Silvennoinen R; Volin L; Elonen E;
    Eur J Haematol; 2007 Jun; 78(6):477-86. PubMed ID: 17391337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Análisis de los resultados en veintitrés casos. (COAP therapy for acute grAnulocytic leukaemia. An assay of the results in 25 cases.) (author's transl)].
    Gil JL; Giralt M; Raichs A
    Sangre (Barc); 1975; 20(4):406-14. PubMed ID: 1062010
    [No Abstract]   [Full Text] [Related]  

  • 20. [Acute myelogenous leukaemia of adults: diagnosis, prognosis and treatment (author's transl)].
    Abbrederis K; Michlmayr G; Schmalzl F; Huber H; Braunsteiner H
    Dtsch Med Wochenschr; 1973 Sep; 98(38):1743-7. PubMed ID: 4517776
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.